Treatment of type 2 diabetes with saxagliptin: a pharmacoeconomic evaluation in Argentina
Author
Abstract
Suggested Citation
DOI: 10.1186/2191-1991-3-11
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Weisbrod, Burton A, 1991. "The Health Care Quadrilemma: An Essay on Technological Change, Insurance, Quality of Care, and Cost Containment," Journal of Economic Literature, American Economic Association, vol. 29(2), pages 523-552, June.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Jonathan Karnon & Hossein Haji Ali Afzali, 2014. "When to Use Discrete Event Simulation (DES) for the Economic Evaluation of Health Technologies? A Review and Critique of the Costs and Benefits of DES," PharmacoEconomics, Springer, vol. 32(6), pages 547-558, June.
- Jinsong Geng & Hao Yu & Yiwei Mao & Peng Zhang & Yingyao Chen, 2015. "Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes," PharmacoEconomics, Springer, vol. 33(6), pages 581-597, June.
- Dongzhe Hong & Lei Si & Minghuan Jiang & Hui Shao & Wai-kit Ming & Yingnan Zhao & Yan Li & Lizheng Shi, 2019. "Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review," PharmacoEconomics, Springer, vol. 37(6), pages 777-818, June.
- Alexandre Baptista & Inês Teixeira & Sónia Romano & António Vaz Carneiro & Julian Perelman, 2017. "The place of DPP-4 inhibitors in the treatment algorithm of diabetes type 2: a systematic review of cost-effectiveness studies," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(8), pages 937-965, November.
- Hui Shao & Vivian Fonseca & Charles Stoecker & Shuqian Liu & Lizheng Shi, 2018. "Novel Risk Engine for Diabetes Progression and Mortality in USA: Building, Relating, Assessing, and Validating Outcomes (BRAVO)," PharmacoEconomics, Springer, vol. 36(9), pages 1125-1134, September.
- Xinyang Hua & Thomas Wai-Chun Lung & Andrew Palmer & Lei Si & William H. Herman & Philip Clarke, 2017. "How Consistent is the Relationship between Improved Glucose Control and Modelled Health Outcomes for People with Type 2 Diabetes Mellitus? a Systematic Review," PharmacoEconomics, Springer, vol. 35(3), pages 319-329, March.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Kurt Hornschild & Stephan Raab & Jörg-Peter Weiß, 2005. "Die Medizintechnik am Standort Deutschland: Chancen und Risiken durch technologische Innovationen, Auswirkungen auf und durch das nationale Gesundheitssystem sowie potentielle Wachstumsmärkte im Ausla," DIW Berlin: Politikberatung kompakt, DIW Berlin, German Institute for Economic Research, edition 2, volume 10, number pbk10.
- Daron Acemoglu & Amy Finkelstein, 2008.
"Input and Technology Choices in Regulated Industries: Evidence from the Health Care Sector,"
Journal of Political Economy, University of Chicago Press, vol. 116(5), pages 837-880, October.
- Daron Acemoglu & Amy Finkelstein, 2006. "Input and Technology Choices in Regulated Industries: Evidence From the Health Care Sector," NBER Working Papers 12254, National Bureau of Economic Research, Inc.
- Wasem, Jurgen, 1997. "A study on decentralizing from acute care to home care settings in Germany," Health Policy, Elsevier, vol. 41(Supplemen), pages 109-129, September.
- Tianyan Hu & Sandra L. Decker & Shin-Yi Chou, 2014. "The Impact of Health Insurance Expansion on Physician Treatment Choice: Medicare Part D and Physician Prescribing," NBER Working Papers 20708, National Bureau of Economic Research, Inc.
- Anlauf, Markus & Wigger, Berthold U., 1999. "Health insurance and consumer welfare : The case of monopolistic drug markets," Discussion Papers 565, Institut fuer Volkswirtschaftslehre und Statistik, Abteilung fuer Volkswirtschaftslehre.
- Magnus Lindelow, 2003. "Understanding spatial variation in the utilization of health services: does quality matter?," Economics Series Working Papers WPS/2004-12, University of Oxford, Department of Economics.
- Djellal, Faridah & Gallouj, FaIz, 2005.
"Mapping innovation dynamics in hospitals,"
Research Policy, Elsevier, vol. 34(6), pages 817-835, August.
- Faridah Djellal & Faïz Gallouj, 2005. "Mapping innovation dynamics in hospitals," Post-Print halshs-01133749, HAL.
- Simon Eckermann & Tim Coelli, 2008. "Including quality attributes in a model of health care efficiency: A net benefit approach," CEPA Working Papers Series WP032008, School of Economics, University of Queensland, Australia.
- Laurence Baker & Joanne Spetz, 1999.
"Managed Care and Medical Technology Growth,"
NBER Chapters, in: Frontiers in Health Policy Research, volume 2, pages 27-52,
National Bureau of Economic Research, Inc.
- Laurence Baker & Joanne Spetz, 1999. "Managed Care and Medical Technology Growth," NBER Working Papers 6894, National Bureau of Economic Research, Inc.
- Bardey, David & Cremer, Helmuth & Lozachmeur, Jean-Marie, 2016.
"The design of insurance coverage for medical products under imperfect competition,"
Journal of Public Economics, Elsevier, vol. 137(C), pages 28-37.
- David Bardey & Helmuth Cremer & Jean-Marie Lozachmeur, 2015. "The design of insurance coverage for medical products under imperfect competition," Documentos CEDE 12564, Universidad de los Andes, Facultad de Economía, CEDE.
- David Bardey & Helmuth Cremer & Jean-Marie Lozachmeur, 2015. "The Design of Insurance Coverage for Medical Products under Imperfect Competition," CESifo Working Paper Series 5235, CESifo.
- Bardey, David & Cremer, Helmuth & Lozachmeur, Jean-Marie, 2015. "The design of insurance coverage for medical products under imperfect competition," TSE Working Papers 15-553, Toulouse School of Economics (TSE).
- Bardey, David & Cremer, Helmuth & Lozachmeur, Jean-Marie, 2015. "The Design of Insurance Coverage for Medical Products under Imperfect Competition," IZA Discussion Papers 8815, Institute of Labor Economics (IZA).
- Jacques H. Drèze, 1997.
"Sur la spécificité économique des soins de santé,"
Économie et Prévision, Programme National Persée, vol. 129(3), pages 1-9.
- Drèze, J., 1997. "Sur la spécificité économique des soins de santé," LIDAM Reprints CORE 1288, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
- Karine Lamiraud & Stephane Lhuillery, 2016.
"Endogenous Technology Adoption and Medical Costs,"
Health Economics, John Wiley & Sons, Ltd., vol. 25(9), pages 1123-1147, September.
- Lamiraud, Karine & Lhuillery, Stephane, 2015. "Endogenous Technology Adoption and Medical Costs," ESSEC Working Papers WP1518, ESSEC Research Center, ESSEC Business School.
- Karine Lamiraud & Stéphane Lhuillery, 2016. "Endogenous Technology Adoption and Medical Costs," Post-Print hal-01512885, HAL.
- Pratt, John W & Zeckhauser, Richard J, 1996. "Willingness to Pay and the Distribution of Risk and Wealth," Journal of Political Economy, University of Chicago Press, vol. 104(4), pages 747-763, August.
- Kristopher J. Hult & Tomas J. Philipson, 2012. "Public Liabilities and Health Care Policy," NBER Working Papers 18571, National Bureau of Economic Research, Inc.
- Freedman, Seth & Lin, Haizhen & Simon, Kosali, 2015.
"Public health insurance expansions and hospital technology adoption,"
Journal of Public Economics, Elsevier, vol. 121(C), pages 117-131.
- Seth Freedman & Haizhen Lin & Kosali Simon, 2012. "Public Health Insurance Expansions and Hospital Technology Adoption," Working Papers 2012-08, Indiana University, Kelley School of Business, Department of Business Economics and Public Policy.
- Seth Freedman & Haizhen Lin & Kosali Simon, 2014. "Public Health Insurance Expansions and Hospital Technology Adoption," Working Papers 2014-04, Indiana University, Kelley School of Business, Department of Business Economics and Public Policy.
- Seth Freedman & Haizhen Lin & Kosali Simon, 2014. "Public Health Insurance Expansions and Hospital Technology Adoption," NBER Working Papers 20159, National Bureau of Economic Research, Inc.
- Christian M. Ernst, 2003. "The interaction between cost‐management and learning for major surgical procedures – lessons from asymmetric information," Health Economics, John Wiley & Sons, Ltd., vol. 12(3), pages 199-215, March.
- Stern, S. & Trajtenberg, M., 1998.
"Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking,"
Papers
24-98, Tel Aviv.
- Scott Stern & Manuel Trajtenberg, 1998. "Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking," NBER Working Papers 6851, National Bureau of Economic Research, Inc.
- Thomas Grebel, 2011. "Innovation and Health," Books, Edward Elgar Publishing, number 14375.
- David M. Cutler & Ellen Meara & Seth Richards-Shubik, 2012.
"Induced Innovation and Social Inequality: Evidence from Infant Medical Care,"
Journal of Human Resources, University of Wisconsin Press, vol. 47(2), pages 456-492.
- David M. Cutler & Ellen Meara & Seth Richards, 2009. "Induced Innovation and Social Inequality: Evidence from Infant Medical Care," NBER Working Papers 15316, National Bureau of Economic Research, Inc.
- Jeffrey Clemens & Stan Veuger, 2017.
"Risks To The Returns To Medical Innovation: The Case Of Myriad Genetics,"
Contemporary Economic Policy, Western Economic Association International, vol. 35(2), pages 345-357, April.
- Jeffrey Clemens & Stan Veuger, 2015. "Risks to the Returns to Medical Innovation: The Case of Myriad Genetics," NBER Working Papers 21469, National Bureau of Economic Research, Inc.
More about this item
Keywords
Type 2 Diabetes treatment; Saxagliptin; DPP-4 inhibitors; Pharmacoeconomics; Cost-effectiveness analysis; Latin America; Argentina;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:hecrev:v:3:y:2013:i:1:p:1-9:10.1186/2191-1991-3-11. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/13561 .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.